David Moore

14.8k total citations · 2 hit papers
249 papers, 8.0k citations indexed

About

David Moore is a scholar working on Surgery, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David Moore has authored 249 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Surgery, 42 papers in Epidemiology and 36 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David Moore's work include Ocular Diseases and Behçet’s Syndrome (17 papers), Retinal and Optic Conditions (17 papers) and Microscopic Colitis (13 papers). David Moore is often cited by papers focused on Ocular Diseases and Behçet’s Syndrome (17 papers), Retinal and Optic Conditions (17 papers) and Microscopic Colitis (13 papers). David Moore collaborates with scholars based in United Kingdom, United States and Australia. David Moore's co-authors include Martin Connock, A Fry-Smith, Susan Bayliss, Geoffrey P. Davidson, Malcolm J Price, Mohammed Nabil Quraishi, Tariq Iqbal, Neeraj Bhala, John Marshall and Alya Hussain and has published in prestigious journals such as Nature, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

David Moore

239 papers receiving 7.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Systematic review with meta‐analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection

2017 443 citations David Moore, Malcolm J Price et al. profile →
The use of faecal microbiota transplant as treatment for recurrent or refractoryClostridium difficileinfection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines

2018 251 citations David Moore et al. profile →

Peers

Countries citing papers authored by David Moore

Since Specialization

Citations

This map shows the geographic impact of David Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Moore more than expected).

Fields of papers citing papers by David Moore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Moore. The network helps show where David Moore may publish in the future.

Co-authorship network of co-authors of David Moore

This figure shows the co-authorship network connecting the top 25 collaborators of David Moore. A scholar is included among the top collaborators of David Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Moore. David Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cost Effectiveness of Left Ventricular Assist Devices (LVADs) as Destination Therapy: A Systematic Review 2025 ·PharmacoEconomics - Open ·Tuba Saygın Avşar, Louise Jackson, (unknown), Sophie Beese, Chidubem B. Ogwulu, Hoong Sern Lim, David Quinn, Malcolm J Price, David Moore	0
2	AI as a Medical Device Adverse Event Reporting in Regulatory Databases: Protocol for a Systematic Review 2024 ·JMIR Research Protocols ·Aditya U. Kale, (unknown), (unknown), Henry David Jeffry Hogg, (unknown), Ben Glocker, Su Golder, Justin Waring, Xiaoxuan Liu, David Moore, Alastair K. Denniston	1
3	Clinical and cost-effectiveness of left ventricular assist devices as destination therapy for advanced heart failure: systematic review and economic evaluation 2024 ·Health Technology Assessment ·Sophie Beese, Tuba Saygın Avşar, Malcolm J Price, David Quinn, Hoong Sern Lim, Janine Dretzke, Chidubem B. Ogwulu, Pelham Barton, Louise Jackson, David Moore	3
4	Implementing early rehabilitation and mobilisation for children in UK paediatric intensive care units: the PERMIT feasibility study 2023 ·Health Technology Assessment ·Barnaby R. Scholefield, (unknown), (unknown), Jacqueline Thompson, Joseph C. Manning, Richard Feltbower, (unknown), (unknown), Kevin Morris, David Moore, Nazima Pathan, Fenella J. Kirkham, Rob Forsyth, Tim Rapley	2
5	Evaluating patient-reported outcome measures (PROMs) for future clinical trials in adult patients with optic neuritis 2023 ·Eye ·(unknown), Charles O’Donovan, Olalekan Lee Aiyegbusi, Xiaoxuan Liu, Susan Bayliss, Melanie Calvert, Konrad Pesudovs, Alastair K. Denniston, David Moore, Tasanee Braithwaite	3
6	The impact of a virtual cardiology outpatient clinic in the COVID-19 era 2021 ·Irish Journal of Medical Science (1971 -) ·(unknown), (unknown), (unknown), (unknown), (unknown), David Moore, David Mulcahy, Vincent Maher	7
7	Bringing the World to School: Integrating News and Media Literacy in Elementary Classrooms 2013 ·Journal of Media Literacy Education ·David Moore	16
8	Combined anticoagulation and antiplatelet therapy for high-risk patients with atrial fibrillation: a systematic review 2013 ·Health Technology Assessment ·Deirdre A. Lane, (unknown), David Moore, Martin Connock, A Fry-Smith, (unknown)	23
9	Cost-effectiveness of transcatheter aortic valve implantation (TAVI) for aortic stenosis in patients who are high risk or contraindicated for surgery: a model-based economic evaluation 2013 ·Health Technology Assessment ·Rosanna Orlando, (unknown), (unknown), Saib Khogali, Susan Bayliss, (unknown), David Moore, P Barton	47
10	Optimization of the Localization Performance of Irregular Ambisonic Decoders for Multiple Off-Center Listeners 2010 ·Journal of the Audio Engineering Society ·David Moore, Jonathan P. Wakefield	4
11	Clinical and cost-effectiveness of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for pulmonary arterial hypertension within their licensed indications: a systematic review and economic evaluation 2009 ·Health Technology Assessment ·Yen‐Fu Chen, Sue Jowett, Pelham Barton, K Malottki, Christopher Hyde, J. Simon R. Gibbs, (unknown), A Fry-Smith, Jamie Roberts, David Moore	125
12	Exploiting human spatial resolution in surround sound decoder design 2008 ·University of Huddersfield Repository (University of Huddersfield) ·David Moore, Jonathan P. Wakefield	3
13	The use of economic evaluations in NHS decision-making: a review and empirical investigation 2008 ·Health Technology Assessment ·Iestyn Williams, Shirley McIver, David Moore, Stirling Bryan	104
14	Modeling Blast-Related Brain Injury 2008 ·Open Repository and Bibliography (University of Liège) ·Michelle K. Nyein, Antoine Jérusalem, Raùl Radovitzky, David Moore, Ludovic Noels	6
15	'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis 2008 ·Health Technology Assessment ·(unknown), Martin Connock, Pelham Barton, A Fry-Smith, Paul Aveyard, David Moore	103
16	The design of ambisonic decoders for the itu 5.1 layout with even performance characteristics 2008 ·Journal of the Audio Engineering Society ·David Moore, Jonathan P. Wakefield	5
17	Clinical effectiveness and cost-effectiveness of different models of managing long-term oral anticoagulation therapy: a systematic review and economic modelling 2007 ·Health Technology Assessment ·Martin Connock, (unknown), A Fry-Smith, Sue Jowett, David Fitzmaurice, David Moore, Fujian Song	117
18	The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review 2006 ·Health Technology Assessment ·Martin Connock, Amanda Burls, Emma Frew, A Fry-Smith, A. Juarez-Garcia, Christopher J. McCabe, Allan Wailoo, Keith R. Abrams, N.J. Cooper, Alex J. Sutton, Anthony O’Hagan, David Moore	69
19	Inflammatory Bowel Disease: Working Group Report of the Second World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition 2004 ·Journal of Pediatric Gastroenterology and Nutrition ·Simon Murch, Robert N. Baldassano, Hans A. Büller, Simon Chin, Anne M. Griffiths, Hans Hildebrand, (unknown), (unknown), David Moore, Marina Orsi	2
20	Individual Differences As Moderating Variables: Issues in the Development and Use of Personality Variables 1995 ·ACR North American Advances ·David Moore	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact